Posted in | News | Military Robotics | Automation Electronics | Bomb-Disposal Robotics | Consumer Robotics

iRobot Posts Strong Q3 Results

Related Stories

The third quarter profits of iRobot Corporation have risen as the demand for robots grows. Company revenue for the third quarter rose 20% to $94.2 million. It was also helped by a one-time tax benefit in surpassing its forecast.

The strong results have been aided by international home robotics demands as well as increased government orders for robots. Shares have risen by almost 9% after profits for the third quarter were posted.

iRobot designs robots such as an autonomous home vacuum cleaner (Roomba), the Scooba that scrubs and cleans hard floors, and military and police robots, such as the PackBot. iRobot is a public corporation (NASDAQ: IRBT), based in Bedford, Massachusetts.

Analysts say that with the rising demand for robots the fourth quarter earnings will be expected to touch anywhere between $108 to $113 million. The shares were trading at $19.67 after the announcement.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    iRobot Corporation. (2019, March 19). iRobot Posts Strong Q3 Results. AZoRobotics. Retrieved on July 18, 2025 from https://www.azorobotics.com/News.aspx?newsID=331.

  • MLA

    iRobot Corporation. "iRobot Posts Strong Q3 Results". AZoRobotics. 18 July 2025. <https://www.azorobotics.com/News.aspx?newsID=331>.

  • Chicago

    iRobot Corporation. "iRobot Posts Strong Q3 Results". AZoRobotics. https://www.azorobotics.com/News.aspx?newsID=331. (accessed July 18, 2025).

  • Harvard

    iRobot Corporation. 2019. iRobot Posts Strong Q3 Results. AZoRobotics, viewed 18 July 2025, https://www.azorobotics.com/News.aspx?newsID=331.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit
What Big Pharma Isn’t Telling You About AI Labs

What Big Pharma Isn’t Telling You About AI Labs

How AI and robotics are reshaping pharmaceutical R&D—from automated labs and in silico drug design to the growing tensions around secrecy, transparency, and equitable access in healthcare innovation.

Thought Leaders

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback